Evidence map›Paper›PMID 42512331›Full record

ArticleCancers2026

Psychometric Evaluation of the PRO-CTCAE Average Composite Score: Reliability, Responsiveness, Known-Groups Validity, and Sensitivity to Group Differences.

Minji K Lee, Amylou C Dueck, Blake T Langlais, Gina L Mazza, Gita Thanarajasingam, Allison M Deal, Brie N Noble, Lauren Rogak, Tito R Mendoza, Sandra A Mitchell and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Minji K LeeDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, MN 55905, USA.ORCID 0000-0002-1301-4319
Amylou C DueckDepartment of Quantitative Health Sciences, Mayo Clinic, Scottsdale, AZ 85259, USA.ORCID 0000-0002-9912-1085
Blake T LanglaisDepartment of Quantitative Health Sciences, Mayo Clinic, Scottsdale, AZ 85259, USA.
Gina L MazzaDepartment of Quantitative Health Sciences, Mayo Clinic, Scottsdale, AZ 85259, USA.ORCID 0000-0002-5305-6193
Gita ThanarajasingamDivision of Hematology, Mayo Clinic, Rochester, MN 55905, USA.
Allison M DealLineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599, USA.ORCID 0000-0003-3526-3938
Brie N NobleDepartment of Quantitative Health Sciences, Mayo Clinic, Scottsdale, AZ 85259, USA.
Lauren RogakDepartment of Quantitative Health Sciences, Mayo Clinic, Scottsdale, AZ 85259, USA.ORCID 0009-0009-9430-2256
Tito R MendozaCenter for Cancer Research, National Cancer Institute, Rockville, MD 20850, USA.
Sandra A MitchellDivision of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD 20850, USA.ORCID 0000-0002-4153-9972
Ethan BaschLineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599, USA.

Funding

Women's Cancer ProgramP30CA015083 · NCI · MAYO CLINIC ROCHESTER · PI Lila J. Rutten · 1985 to 2026
$151.3M
CCR NIH HHS HHSN261200800001CNCI NIH HHS HHSN261200800043CNCI NIH HHS HHSN261201000063CNCI NIH HHS P30 CA015083NIH HHS HHSN261200800001E
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

clinical trialsknown-groups validityPRO-CTCAE Average Composite Scoreresponsivenesssensitivity to group differencestest–retest reliability

Identifiers

PMID42512331
PMCPMC13406605

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.